Free Trial

Kesler Norman & Wride LLC Increases Holdings in Select Medical Holdings Corporation (NYSE:SEM)

Select Medical logo with Medical background

Kesler Norman & Wride LLC increased its position in Select Medical Holdings Corporation (NYSE:SEM - Free Report) by 87.4% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 45,417 shares of the health services provider's stock after buying an additional 21,184 shares during the quarter. Kesler Norman & Wride LLC's holdings in Select Medical were worth $758,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors also recently made changes to their positions in SEM. Vanguard Group Inc. raised its position in shares of Select Medical by 1.0% in the 4th quarter. Vanguard Group Inc. now owns 12,712,990 shares of the health services provider's stock worth $239,640,000 after acquiring an additional 131,228 shares in the last quarter. Dimensional Fund Advisors LP boosted its stake in shares of Select Medical by 1.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 4,431,469 shares of the health services provider's stock worth $83,533,000 after buying an additional 62,585 shares during the last quarter. Invesco Ltd. raised its holdings in Select Medical by 48.6% in the 4th quarter. Invesco Ltd. now owns 2,643,943 shares of the health services provider's stock worth $49,838,000 after purchasing an additional 864,852 shares during the period. Principal Financial Group Inc. raised its holdings in shares of Select Medical by 3.1% during the first quarter. Principal Financial Group Inc. now owns 2,476,816 shares of the health services provider's stock valued at $41,363,000 after acquiring an additional 73,308 shares during the last quarter. Finally, Hood River Capital Management LLC increased its holdings in shares of Select Medical by 404.8% in the fourth quarter. Hood River Capital Management LLC now owns 1,755,733 shares of the health services provider's stock valued at $33,096,000 after purchasing an additional 1,407,902 shares during the last quarter. Institutional investors own 89.48% of the company's stock.

Insider Buying and Selling at Select Medical

In related news, CEO David S. Chernow sold 225,000 shares of the stock in a transaction dated Monday, April 28th. The stock was sold at an average price of $18.00, for a total transaction of $4,050,000.00. Following the completion of the transaction, the chief executive officer directly owned 714,516 shares in the company, valued at approximately $12,861,288. This trade represents a 23.95% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Parvinderjit S. Khanuja acquired 21,000 shares of the business's stock in a transaction dated Monday, May 5th. The stock was acquired at an average cost of $15.02 per share, with a total value of $315,420.00. Following the completion of the transaction, the director owned 65,089 shares of the company's stock, valued at approximately $977,636.78. The trade was a 47.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. 11.60% of the stock is owned by insiders.

Select Medical Stock Up 0.8%

NYSE:SEM traded up $0.11 on Friday, reaching $14.72. The stock had a trading volume of 905,485 shares, compared to its average volume of 992,817. The company has a current ratio of 1.16, a quick ratio of 1.16 and a debt-to-equity ratio of 0.87. The company has a 50-day moving average of $15.00 and a 200 day moving average of $16.90. The stock has a market cap of $1.89 billion, a P/E ratio of 10.99, a price-to-earnings-growth ratio of 0.78 and a beta of 1.32. Select Medical Holdings Corporation has a 12-month low of $14.03 and a 12-month high of $40.98.

Select Medical (NYSE:SEM - Get Free Report) last announced its earnings results on Thursday, May 1st. The health services provider reported $0.44 earnings per share for the quarter, missing the consensus estimate of $0.45 by ($0.01). Select Medical had a net margin of 2.81% and a return on equity of 11.04%. The firm had revenue of $1.35 billion for the quarter, compared to the consensus estimate of $1.40 billion. During the same period in the prior year, the business earned $0.75 EPS. The company's quarterly revenue was down 24.4% compared to the same quarter last year. On average, research analysts predict that Select Medical Holdings Corporation will post 1.17 earnings per share for the current year.

Select Medical declared that its Board of Directors has initiated a share repurchase program on Thursday, May 1st that permits the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization permits the health services provider to purchase up to 42.6% of its stock through open market purchases. Stock repurchase programs are generally an indication that the company's leadership believes its shares are undervalued.

Select Medical Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, May 29th. Investors of record on Thursday, May 15th were paid a $0.0625 dividend. This represents a $0.25 annualized dividend and a yield of 1.70%. The ex-dividend date was Thursday, May 15th. Select Medical's dividend payout ratio is 18.66%.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on the company. Royal Bank Of Canada lowered their price target on Select Medical from $23.00 to $19.00 and set an "outperform" rating for the company in a research report on Wednesday, May 7th. Mizuho assumed coverage on Select Medical in a research note on Wednesday, April 16th. They issued an "outperform" rating and a $25.00 price objective on the stock. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat, Select Medical has an average rating of "Moderate Buy" and an average price target of $26.00.

Check Out Our Latest Report on Select Medical

About Select Medical

(Free Report)

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.

See Also

Institutional Ownership by Quarter for Select Medical (NYSE:SEM)

Should You Invest $1,000 in Select Medical Right Now?

Before you consider Select Medical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Select Medical wasn't on the list.

While Select Medical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Watch Before Monday: Stocks to Load Up on Before Earnings
3 Hot Growth Stocks to Watch Right Now!
Don’t Miss These Top 3 Defense Stocks Set To Gain

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines